BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.

The latest biotech and pharmaceutical news from BioSpace. News. ... even as the pharma challenges the ...

3 天之前 · The biotech said it has dosed the first participant in a Phase 3 study of its in vivo gene editing treatment. Elsewhere, the FDA imposed a hold on Atara and lifted another on Amylyx. By BioPharma Dive staff • Jan. 22, 2025

5 天之前 · In some instances, such as the purchase of a private biotech, data for each category either wasn't applicable or wasn't readily available. Finally, BioPharma Dive updates the tracker when deals are announced. Sometimes, transactions fall through or another company outbids the original acquirer.

2010年12月11日 · In this episode, presented by the Genscript Biotech Global Forum 2025, BioSpace’s Head of Insights Lori Ellis talks to Tom Whitehead, co-founder of the Emily Whitehead Foundation, about how standard care, cell and gene therapies and their impact on patients.

2024年1月16日 · 5 questions facing pharma in 2024 By Jonathan Gardner and Ned Pagliarulo • Jan. 10, 2024 New drugs for obesity and cancer are the focus of many pharma companies, some of which are also grappling with how to manufacture complex …

2025年1月16日 · ‘The bar has risen’: China’s biotech gains push US companies to adapt Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors and executives interviewed by BioPharma Dive.

2025年1月14日 · Pharma companies and U.S.-based biotechs have for years turned to China for help making drugs or running clinical trials. Increasingly, they’re looking to China to acquire new drug prospects they can plug directly into their pipelines — a trend that could have ripple effects across the U.S. biotech ecosystem.

5 天之前 · The Biotech Bay Hotbed includes the San Francisco Bay, Menlo Park and Palo Alto regions of Northern California. California is a dominant force in the life sciences sector, hosting global leaders and start-ups alike and is a center for cutting-edge science and medicine. Major research universities in ...

2024年10月1日 · Always following closely on the heels of ASCO, BIO’s International Convention is a important convener for biotech and pharma companies’ business development teams. It’s also regularly a venue for industry leaders to discuss and …